Open access · CC-BY
via OpenAlex
Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure
Mingming Gao, Zhaoer Yu, Dan Yao, Yating Qian, Qi Wang, Ruizhe Jia
Tissue and Cell · 2021 · ▲ 48 citations
Abstract
Both intrauterine adhesions (IUA) and premature ovarian failure (POF) have plagued women all over the world for a long time. It is well known that all invasive operations involving the uterus can disrupt its structural and functional integrity to a varying degree, which inevitably lead to abnormal scar formation, such as IUA, also known as Asherman's syndrome with symptoms like hypomenorrhea or infertility. Another reproductive disorder that causes infertility is primary ovarian insufficiency (POI) or POF, which is a degenerative phenomenon in the ovary among women under the age of 40. In recent years, various types of stem cells, especially mesenchymal stem cells (MSCs) have been widely used in reproductive medicine due to their properties, such as immunoregulation, anti-inflammation, angiogenesis, anti-apoptosis, and trophicity. However, the extensive clinical application of cell therapy is impeded by their safety, cost, and manufacturing. In this review, we sought to summarize the recent advances in using different types of MSCs in treating uterine scars and POF. We also describe several biological pathways and molecules involved in animal studies and clinical application; extracellular vesicles secreted by MSCs may be a promising attractive tool to ensure the treatment of infertility by restoring normal reproductive function.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.tice.2021.101676
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Gao, M., Yu, Z., Yao, D., Qian, Y., Wang, Q., & Jia, R. (2021). Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure. <em>Tissue and Cell</em>. https://doi.org/10.1016/j.tice.2021.101676
Vancouver
Gao M, Yu Z, Yao D, Qian Y, Wang Q, Jia R. Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure. Tissue and Cell. 2021. doi:10.1016/j.tice.2021.101676.
BibTeX
@article{mingming2021Mesenc,
title = {Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure},
author = {Mingming Gao and Zhaoer Yu and Dan Yao and Yating Qian and Qi Wang and Ruizhe Jia},
journal = {Tissue and Cell},
year = {2021},
doi = {10.1016/j.tice.2021.101676},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Pharmaceutical Design 2013
Open access · OA
Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy
International Journal of Molecular Medicine 2017
Citation only
Senescence of mesenchymal stem cells (Review)
Springer eBooks 2016
Citation only
Mesenchymal Stem Cells for Stroke Therapy
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Arthritis Research & Therapy 2015
Open access · OA
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Cellular and Molecular Immunology 2023
Open access · CC-BY